Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04961398 · ClinicalTrials.gov registry record
Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 9
- Enrollment target
NCT04961398: Completed study, sponsored by Heidelberg Engineering.
NCT04961398 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04961398 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Evaluation of effect of various OCT scan speeds and filters on parameter measurements.
Primary Outcome
ETDRS grid (9 sectors)
Interventions
- DEVICE OCT imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2021-06-24 |
What the finished NCT04961398 record still lists
NCT04961398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which OCT imaging is the first listed.
NCT04961398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04961398 about?
NCT04961398 is a clinical study titled "Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements". Evaluation of effect of various OCT scan speeds and filters on parameter measurements.
What is the current status of trial NCT04961398?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2021-06-21. Estimated completion is 2021-06-24.
What interventions are being tested in trial NCT04961398?
The interventions under investigation include: OCT imaging (DEVICE).
Who is sponsoring clinical trial NCT04961398?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI